CSLMEX:CSL N 83 OCF Yield % is 3.52 as of Jun. 25, 2026, which is 23% above its 10-year median of 2.86. GuruFocus rates MEX:CSL N with a GF Score™ of 83/100 and a GF Value™ of MXN4,931.99. The stock has 7 warning signs investors should review. Among 1,419 Biotechnology companies, CSL ranks better than 87.39% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for CSL's OCF Yield % or its related term are showing as below:
MEX:CSL N'
s OCF Yield % Range Over the Past 10 Years
Min: 1.55 Med: 2.86 Max: 11.64
Current: 3.52
During the past 13 years, the highest OCF Yield % of CSL was 11.64%. The lowest was 1.55%. And the median was 2.86%.
MEX:CSL N's OCF Yield % is ranked better than 87.39% of 1419
companies
in the Biotechnology industry
Industry Median: -8.46
vs MEX:CSL N: 3.52
CSL's OCF Margin % for the quarter that ended in Dec. 2025 was %.
CSL OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
CSL OCF Yield % Related Terms
CSL OCF Yield % Historical Data
* Premium members only.
The historical data trend for CSL's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:CSL N vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, CSL's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CSL OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CSL's OCF Yield % distribution charts can be found below:
* The bar in red indicates where CSL's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSL (MEX:CSL N) has a OCF Yield % of 3.52 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on CSL and its competitors. This is 23% above median its historical median of 2.86. Over the past decade, CSL's OCF Yield % has ranged from 1.55 to 11.64. According to the industry distribution chart, CSL ranks #179 out of 1419 companies in the Biotechnology industry, placing it in the top 12.6%.
Is CSL's OCF Yield % too high?
CSL's current OCF Yield % of 3.52 is 23% above median its 10-year median of 2.86. Over the past 10 years, this metric has ranged from a low of 1.55 to a high of 11.64. Based on the distribution chart, CSL ranks #179 out of 1419 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, CSL has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does CSL's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CSL ranks #179 out of 1419 companies for OCF Yield %. This places CSL in the top 13% of its industry — outperforming the majority of peers. Historically, CSL's own OCF Yield % has ranged from 1.55 to 11.64 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on CSL and its competitors. CSL's current OCF Yield % is 3.52, which is 23% above median its own 10-year median of 2.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSL stock overvalued right now?
CSL (MEX:CSL N) has a current OCF Yield % of 3.52. The stock's GF Value™ is MXN4,931.99, compared to a current price of MXN2,081.30 — trading 57.8% below its estimated fair value. The current OCF Yield % is 3.52, which is 23% above median its 10-year median of 2.86. CSL's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For CSL (MEX:CSL N), the current OCF Yield % is 3.52 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CSL (MEX:CSL N) Overvalued in 2026?
Based on GuruFocus' analysis, CSL stock appears to be undervalued.
The current stock price of MXN2,081.30 is trading 57.8% below its estimated GF Value™ of MXN4,931.99.
Key valuation signals for MEX:CSL N:
OCF Yield %: 3.52 (23% above median its 10-year median of 2.86)
GF Value™: MXN4,931.99 vs. price of MXN2,081.30 (57.8% below fair value)
No single metric tells the full story. See the MEX:CSL N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Seqirus is the world's second-largest influenza vaccination business and was acquired in fiscal 2016. CSL Vifor is an iron deficiency and nephrology business and was acquired in fiscal 2023. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.
83GF Score
Get the complete analysis for MEX:CSL N
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CSL N has been successfully added to your 
